Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
DKK | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 758 | 900 | 1,416 | 2,053 | 2,454 | 2,839 | 3,632 | 5,545 | 6,078 | 6,541 | | 6,541 |
% Growth | NA | 18.7% | 57.4% | 45.0% | 19.5% | 15.7% | 27.9% | 52.7% | 9.6% | 7.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (447) | (527) | (803) | (1,237) | (1,458) | (1,683) | (2,299) | (3,772) | (4,376) | (4,634) | | (4,634) |
Gross Profit | 311 | 373 | 613 | 817 | 996 | 1,155 | 1,333 | 1,772 | 1,703 | 1,906 | | 1,906 |
% Revenue | 41.1% | 41.4% | 43.3% | 39.8% | 40.6% | 40.7% | 36.7% | 32.0% | 28.0% | 29.1% | | 29.1% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (4) | (4) | (10) | (12) | (12) | (17) | (37) | (41) | (55) | (53) | | (53) |
General and Admin | (100) | (121) | (201) | (290) | (367) | (394) | (503) | (764) | (936) | (943) | | (943) |
Other Inc / (Exp) | 0 | (118) | (128) | (188) | (98) | (275) | (47) | (162) | (167) | (153) | | (153) |
Total Operating Exp | (104) | (243) | (338) | (491) | (476) | (686) | (587) | (967) | (1,157) | (1,149) | | (1,149) |
| | | | | | | | | | | | |
Operating Income | 208 | 130 | 274 | 326 | 519 | 469 | 746 | 806 | 546 | 757 | | 757 |
% Revenue | 27.4% | 14.5% | 19.4% | 15.9% | 21.2% | 16.5% | 20.5% | 14.5% | 9.0% | 11.6% | | 11.6% |
| | | | | | | | | | | | |
Interest Expense | 1 | (52) | (71) | (70) | (22) | (18) | (18) | (49) | (114) | (133) | | (133) |
Pre-tax Income | 208 | 78 | 203 | 256 | 497 | 452 | 728 | 757 | 432 | 624 | | 624 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (21) | (45) | (62) | (74) | (109) | (130) | (153) | (154) | (128) | (157) | | (157) |
Net Income to Company | 188 | 33 | 142 | 181 | 388 | 322 | 574 | 603 | 304 | 468 | | 468 |
% Margin | 24.8% | 3.6% | 10.0% | 8.8% | 15.8% | 11.3% | 15.8% | 10.9% | 5.0% | 7.1% | | 7.1% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | (1) | 3 | | 3 |
Net Income to Stockholders | 188 | 33 | 142 | 181 | 388 | 322 | 576 | 603 | 304 | 470 | | 470 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 188 | 33 | 142 | 181 | 388 | 322 | 576 | 603 | 304 | 470 | | 470 |
% Margin | 24.8% | 3.6% | 10.0% | 8.8% | 15.8% | 11.3% | 15.9% | 10.9% | 5.0% | 7.2% | | 7.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 339.60 | 0.47 | 2.92 | 3.65 | 7.90 | 6.56 | 11.74 | 12.26 | 6.13 | 9.67 | | 9.67 |
Diluted EPS (Continuing Ops) | 339.60 | 0.47 | 2.92 | 3.65 | 7.88 | 6.53 | 11.59 | 12.15 | 6.09 | 9.58 | | 9.58 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.55 | 69.28 | 48.52 | 49.69 | 49.18 | 49.10 | 49.09 | 49.20 | 49.50 | 48.60 | | 48.60 |
WA Diluted Shares Out. | 0.55 | 69.28 | 48.52 | 49.72 | 49.29 | 49.32 | 49.69 | 49.70 | 49.80 | 49.10 | | 49.10 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 208 | 78 | 203 | 256 | 497 | 452 | 728 | 757 | 432 | 624 | | 624 |
Addback: Net Interest Expense | (1) | 52 | 71 | 70 | 22 | 18 | 18 | 49 | 114 | 133 | | 133 |
Addback: Other Non Operating Expenses, Total | (0) | 9 | (1) | 38 | (8) | 34 | 37 | 26 | 32 | 28 | | 28 |
Addback: Depreciation & Amortization | 9 | 70 | 95 | 117 | 111 | 111 | 81 | 151 | 138 | 96 | | 96 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 35 | 14 | 1 | 4 | 0 | 38 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | (5) | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 19 | 33 | 0 | 141 | (79) | 8 | 1 | 3 | | 3 |
Adjusted EBITDA | 217 | 245 | 401 | 516 | 626 | 756 | 824 | 986 | 717 | 885 | | 885 |
% Margin | 28.6% | 27.2% | 28.3% | 25.1% | 25.5% | 26.6% | 22.7% | 17.8% | 11.8% | 13.5% | | 13.5% |
| | | | | | | | | | | | |
Adjusted EBIT | 207 | 174 | 306 | 399 | 516 | 645 | 743 | 834 | 579 | 788 | | 788 |
% Margin | 27.4% | 19.4% | 21.6% | 19.4% | 21.0% | 22.7% | 20.4% | 15.0% | 9.5% | 12.1% | | 12.1% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 188 | 33 | 142 | 181 | 388 | 322 | 574 | 603 | 304 | 468 | | 468 |
Addback: Unusual Items | 0 | 35 | 33 | 34 | 4 | 141 | (40) | 3 | 1 | 3 | | 3 |
Less: Tax Benefit of Unusual Items (26%) | 0 | (9) | (9) | (9) | (1) | (37) | 10 | (1) | (0) | (1) | | (1) |
Adjusted Net Income | 188 | 59 | 166 | 207 | 392 | 426 | 545 | 605 | 304 | 469 | | 469 |
% Margin | 24.8% | 6.5% | 11.7% | 10.1% | 16.0% | 15.0% | 15.0% | 10.9% | 5.0% | 7.2% | | 7.2% |